Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Science Translational Medicine|January 5, 2018
A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetesIsabelle Serr, Martin G Scherm, Adam M Zahm, et al.
Diabetologia|December 11, 2025
Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohortJennifer J Couper, Helena Oakey, Megan A S Penno, et al.
JAMA|May 21, 2026
Screening Children for Early-Stage Type 1 DiabetesChristiane Winkler, Nadine Friedl, Renate Abt, et al.
Diabetologia|February 11, 2025
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]Moshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetes Care|September 6, 2024
Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298Moshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetes Care|June 24, 2024
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 DiabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetologia|September 4, 2024
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetologia|June 23, 2024
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Science Translational Medicine|January 5, 2018
A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetesIsabelle Serr, Martin G Scherm, Adam M Zahm, et al.
Diabetologia|December 11, 2025
Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohortJennifer J Couper, Helena Oakey, Megan A S Penno, et al.
JAMA|May 21, 2026
Screening Children for Early-Stage Type 1 DiabetesChristiane Winkler, Nadine Friedl, Renate Abt, et al.
Diabetologia|February 11, 2025
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter]Moshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetes Care|September 6, 2024
Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298Moshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetes Care|June 24, 2024
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 DiabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetologia|September 4, 2024
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.
Diabetologia|June 23, 2024
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetesMoshe Phillip, Peter Achenbach, Ananta Addala, et al.
Pageof 11